Comment by
JackLambert on Jun 16, 2021 4:37pm
Very nice catch L being stoopid. I did not realize that the Astral ventilator we support is a Resmed product. I thought it was Philips. Resmed was over $236 today. With a whopping PE of 76. someone please explain this all to me. In simple terms so I don't get lost. Patience,....
Comment by
lscfa on Jul 07, 2021 3:22pm
from Rotech prospectus: Contracts with the VA that generated approximately 12.4% of our revenue in 2020 will expire in 2021 unless further extended.
Comment by
JackLambert on Jul 07, 2021 4:02pm
I assume that "our revenue" means Rotech's? Are you suggesting 90 million of revenues might be up for bidding by VMD?
Comment by
lscfa on Jul 07, 2021 4:03pm
Rotech prospectus says $62 million in revenue was from VA in 2020.
Comment by
JackLambert on Jul 07, 2021 4:04pm
Ok. I did 12.% of 750. My bad. but the issue is we could bid on this ?
Comment by
JackLambert on Jul 07, 2021 4:50pm
And the VA business is value add not CMS bidding / billing ,....
Comment by
ValueCat on Jul 14, 2021 3:00pm
interesting catch. But if the VA is already doing at home ventilation, why the need for a lengthy "study"?
Comment by
lscfa on Jul 26, 2021 12:06pm
I don't think Rotech is doing ventilators with the VA. They started the vent prodcut line on 2017 and had only 7400 vent patients in 2020.
Comment by
lscfa on Jul 26, 2021 12:27pm
p.s. Rotech vent growth mainly from acquistions... Ventilators. Rental revenues from ventilators increased 52.9% primarily due to growth in market share coupled with growth driven by COVID-19 patients and two of our acquisitions whose primary focus was ventilator rentals.